In a time of increasingly individualized healthcare, Elizabeth Philp has become a significant force of innovation, especially in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the helm of a drive to make bespoke medications more available, challenging the traditional one-size-fits-all approach